Medpace Holdings (MEDP) reported $2.5B in revenue for fiscal 2025, +20.0% year on year. That ranks #1203 by revenue among 2853 SEC filers and #106 in Healthcare. Net income was $451M, a net margin of 17.8%. Revenue has grown 22.0% a year on average since 2016 ($422M then). The fiscal 2025 balance sheet shows $2.0B in total assets, $497M in cash and $0 in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $2.5B | +20.0% | FY20252025-12-31 |
| Gross profit | Not reported | — | |
| Operating incomeOperatingIncomeLoss | $535M | +19.7% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $451M | +11.6% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $713M | +17.1% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $31.4M | −14.2% | FY20252025-12-31 |
| Total assetsAssets | $2.0B | −6.0% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $459M | −44.4% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $497M | −25.8% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $0 | −100.0% | FY20192019-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $707M | $124M | Open → |
| Q2 20262026-06-30 | $707M | $121M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 28 of 161 companies compared | 17.8% | |
| Operating marginRank 32 of 160 companies compared | 21.1% | |
| Cash as share of revenueRank 54 of 160 companies compared | 19.6% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Medpace Holdings, Inc.
- Ticker
- MEDP
- Exchange
- Nasdaq
- SIC classification
- Services-Commercial Physical & Biological Research (8731)
- Fiscal year end
- 12-31
- CIK
- 0001668397
Filings
- 10-QJul 23, 2026Open filing →
- 10-QApr 23, 2026Open filing →
- 10-KFeb 10, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Fortrea HoldingsFTRE | $2.7B | −$989M |
| Envista HoldingsNVST | $2.7B | $47.0M |
| InsuletPODD | $2.7B | $247M |
| Medpace HoldingsMEDP | $2.5B | $451M |
| ChemedCHE | $2.5B | $265,238 |
| Teladoc HealthTDOC | $2.5B | −$200M |
| Aveanna HealthcareAVAH | $2.4B | $225,034 |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Medpace Holdings — Key figures |url=https://companiesranked.com/en/company/medpace-holdings |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Medpace Holdings — Key figures. CompaniesRanked. https://companiesranked.com/en/company/medpace-holdingsBibTeX
@misc{companiesranked-en-company-medpace-holdings-2026,
author = {{CompaniesRanked}},
title = {{Medpace Holdings — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/medpace-holdings}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001668397-26-000006 · February 10, 2026
{{cite web |title=Medpace Holdings — Key figures — 10-K (0001668397-26-000006) |url=https://www.sec.gov/Archives/edgar/data/1668397/000166839726000006/medp-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.